Efficacy and Safety of Tirzepatide for Weight Management
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2026-06-30
Target enrollment:
Participant gender:
Summary
The goal of this study is to learn if tirzepatide helps people manage their weight safely. It will include adults in Bangladesh who are overweight or obese, with or without type 2 diabetes. The main questions it aims to answer are:
Does tirzepatide help people lose weight?
What side effects do people experience while taking tirzepatide?
All participants will:
Receive tirzepatide as a weekly injection, starting at 2.5 mg and gradually increasing to 15 mg.
Continue the treatment for 52 weeks (12 months).
Visit the clinic for regular checkups and tests.
Researchers will measure changes in body weight, BMI, waist size, blood sugar, blood pressure, and cholesterol levels. They will also track any side effects and assess the participants' overall health and quality of life during the study.